Skip to content
galux-to-present-preclinical-data-on-<b>ai</b>-designed-pd-1/il-18v-immunocytokine-at-aacr-2026

Galux to Present Preclinical Data on AI-Designed PD-1/IL-18v Immunocytokine at AACR 2026

Galux is redefining the future of drug discovery through protein design AI. The company combines deeplearning with the physical principles of …

colind88

Back To Top